Nanostim Leadless Pacemaker
Device
Abbott Laboratories
Total Payments
$947,169
Transactions
246
Doctors
1
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2020 | $787.50 | 1 | 1 |
| 2019 | $946,381 | 245 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $946,381 | 245 | 99.9% |
| Consulting Fee | $787.50 | 1 | 0.1% |
Payments by Type
Research
$946,381
245 transactions
General
$787.50
1 transactions
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A safety and effectiveness trial for a leadless pacemaker system | Abbott Laboratories | $946,381 | 0 |
Top Doctors Receiving Payments for Nanostim Leadless Pacemaker
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | New Orleans, LA | $946,381 | 245 |
| , M.D | Cardiovascular Disease | Columbus, OH | $787.50 | 1 |
Ad
Manufacturing Companies
- Abbott Laboratories $947,169
Product Information
- Type Device
- Total Payments $947,169
- Total Doctors 1
- Transactions 246
About Nanostim Leadless Pacemaker
Nanostim Leadless Pacemaker is a device associated with $947,169 in payments to 1 healthcare providers, recorded across 246 transactions in the CMS Open Payments database. The primary manufacturer is Abbott Laboratories.
Payment data is available from 2019 to 2020. In 2020, $787.50 was paid across 1 transactions to 1 doctors.
The most common payment nature for Nanostim Leadless Pacemaker is "Unspecified" ($946,381, 99.9% of total).
Nanostim Leadless Pacemaker is associated with 1 research study, including "A safety and effectiveness trial for a leadless pacemaker system" ($946,381).